FDA under pressure to relax drug rules

Nature. 2012 Dec 6;492(7427):19. doi: 10.1038/492019a.
No abstract available

Publication types

  • News

MeSH terms

  • Aminoglycosides
  • Anti-Bacterial Agents*
  • Cause of Death
  • Clinical Trials as Topic / legislation & jurisprudence
  • Drug Approval / legislation & jurisprudence*
  • Drug Approval / methods*
  • Drug Approval / statistics & numerical data
  • Drug Industry / legislation & jurisprudence*
  • Humans
  • Ketolides / adverse effects
  • Lipoglycopeptides
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Ketolides
  • Lipoglycopeptides
  • telithromycin
  • telavancin